Certainty at Last? a “New†Framework for Electronic Contracting in Singapore

Singapore is the first Asian country to accede to the UNCITRAL Convention on the Use of Electronic Communications in International Contracts. Singapore is not only the first Asian nation to accede to the CUECIC but also the first nation to implement some of its provisions locally. It is these provisions that are the subject of this paper. The ETA is significantly wider in scope than the Convention, as it deals not only with electronic contracting but also with the use of electronic communications in the public sector, the liability of network service providers and the remote authentication procedures.[1] This paper examines how the provisions transplanted from the Convention interface with the principles of contract law. Do they create the long-awaited “certainty†in the controversial field of e-commerce? As Singapore’s contract law is predominantly based on English common law, the problems discussed herein will be encountered in any legal system relying on similar principle. [1] Joint IDA-AGC Review of the Electronic Transactions Act Proposed Amendments, 2009, (“Joint Reviewâ€) para 2.16.3

Book Review: Drafting and Negotiating IT Contracts, 3rd Ed

This book is basic. Basic in the good sense: it is the first go-to work for IT professionals, especially procurement or contract managers and possibly also for lawyers that are starting their careers in the field of negotiating and drafting IT contracts. ACCESS PDF FILE FOR FULL REVIEW

Prediction of Small for Gestational Age Infants in Healthy Nulliparous Women Using Clinical and Ultrasound Risk Factors Combined with Early Pregnancy Biomarkers

Objective Most small for gestational age pregnancies are unrecognised before birth, resulting in substantial avoidable perinatal mortality and morbidity. Our objective was to develop multivariable prediction models for small for gestational age combining clinical risk factors and biomarkers at 15±1 weeks’ with ultrasound parameters at 20±1 weeks’ gestation. Methods Data from 5606 participants in the Screening for Pregnancy Endpoints (SCOPE) cohort study were divided into Training (n = 3735) and Validation datasets (n = 1871). The primary outcomes were All-SGA (small for gestational age with birthweight <10th customised centile), Normotensive-SGA (small for gestational age with a normotensive mother) and Hypertensive-SGA (small for gestational age with an hypertensive mother). The comparison group comprised women without the respective small for gestational age phenotype. Multivariable analysis was performed using stepwise logistic regression beginning with clinical variables, and subsequent additions of biomarker and then ultrasound (biometry and Doppler) variables. Model performance was assessed in Training and Validation datasets by calculating area under the curve. Results 633 (11.2%) infants were All-SGA, 465(8.2%) Normotensive-SGA and 168 (3%) Hypertensive-SGA. Area under the curve (95% Confidence Intervals) for All-SGA using 15±1 weeks’ clinical variables, 15±1 weeks’ clinical+ biomarker variables and clinical + biomarkers + biometry /Doppler at 20±1 weeks’ were: 0.63 (0.59–0.67), 0.64 (0.60–0.68) and 0.69 (0.66–0.73) respectively in the Validation dataset; Normotensive-SGA results were similar: 0.61 (0.57–0.66), 0.61 (0.56–0.66) and 0.68 (0.64–0.73) with small increases in performance in the Training datasets. Area under the curve (95% Confidence Intervals) for Hypertensive-SGA were: 0.76 (0.70–0.82), 0.80 (0.75–0.86) and 0.84 (0.78–0.89) with minimal change in the Training datasets. Conclusion Models for prediction of small for gestational age, which combine biomarkers, clinical and ultrasound data from a cohort of low-risk nulliparous women achieved modest performance. Incorporation of biomarkers into the models resulted in no improvement in performance of prediction of All-SGA and Normotensive-SGA but a small improvement in prediction of Hypertensive-SGA. Our models currently have insufficient reliability for application in clinical practice however, they have potential utility in two-staged screening tests which include third trimester biomarkers and or fetal biometry